Toji Miyagawa
Overview
Explore the profile of Toji Miyagawa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
336
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Casaletto K, Saloner R, Kornak J, Staffaroni A, Villeda S, Paolillo E, et al.
Brain Commun
. 2025 Jan;
7(1):fcae432.
PMID: 39816189
The largest risk factor for dementia is age. Heterochronic blood exchange studies have uncovered age-related blood factors that demonstrate 'pro-aging' or 'pro-youthful' effects on the mouse brain. The clinical relevance...
2.
Ferreira D, Przybelski S, Lesnick T, Diaz-Galvan P, Schwarz C, Murray M, et al.
JAMA Neurol
. 2025 Jan;
82(3):285-294.
PMID: 39804619
Importance: Although 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) is a well-established cross-sectional biomarker of brain metabolism in dementia with Lewy bodies (DLB), the longitudinal change in FDG-PET has not been characterized....
3.
Miyagawa T, Vernon C, Przybelski S, Min P, Fields J, Dickerson B, et al.
Parkinsonism Relat Disord
. 2024 Sep;
128:107144.
PMID: 39276720
Our research found out, from I-FP-CIT SPECT scans of three familial frontotemporal dementia (fFTD) individuals with MAPT N279K mutation and similar autopsy findings of frontotemporal degeneration with severe neuronal loss...
4.
Ulugut H, Bertoux M, Younes K, Montembeault M, Fumagalli G, Samanci B, et al.
Alzheimers Dement
. 2024 Jul;
20(8):5647-5661.
PMID: 38982845
Introduction: Although frontotemporal dementia (FTD) with right anterior temporal lobe (RATL) predominance has been recognized, a uniform description of the syndrome is still missing. This multicenter study aims to establish...
5.
Paolillo E, Casaletto K, Clark A, Taylor J, Heuer H, Wise A, et al.
JMIR Aging
. 2024 Jun;
7:e52831.
PMID: 38922667
Background: Frontotemporal lobar degeneration (FTLD) is a leading cause of dementia in individuals aged <65 years. Several challenges to conducting in-person evaluations in FTLD illustrate an urgent need to develop...
6.
Saloner R, Staffaroni A, Dammer E, Johnson E, Paolillo E, Wise A, et al.
Res Sq
. 2024 Apr;
PMID: 38585969
The pathophysiological mechanisms driving disease progression of frontotemporal lobar degeneration (FTLD) and corresponding biomarkers are not fully understood. We leveraged aptamer-based proteomics (> 4,000 proteins) to identify dysregulated communities of...
7.
Mak E, Reid R, Przybelski S, Lesnick T, Schwarz C, Senjem M, et al.
NPJ Parkinsons Dis
. 2024 Apr;
10(1):76.
PMID: 38570511
Dementia with Lewy bodies (DLB) is a neurodegenerative condition often co-occurring with Alzheimer's disease (AD) pathology. Characterizing white matter tissue microstructure using Neurite Orientation Dispersion and Density Imaging (NODDI) may...
8.
Staffaroni A, Clark A, Taylor J, Heuer H, Sanderson-Cimino M, Wise A, et al.
JAMA Netw Open
. 2024 Apr;
7(4):e244266.
PMID: 38558141
Importance: Frontotemporal lobar degeneration (FTLD) is relatively rare, behavioral and motor symptoms increase travel burden, and standard neuropsychological tests are not sensitive to early-stage disease. Remote smartphone-based cognitive assessments could...
9.
Arnaldi D, Mattioli P, Raffa S, Pardini M, Massa F, Iranzo A, et al.
Ann Neurol
. 2024 Mar;
95(6):1178-1192.
PMID: 38466158
Objective: To apply a machine learning analysis to clinical and presynaptic dopaminergic imaging data of patients with rapid eye movement (REM) sleep behavior disorder (RBD) to predict the development of...
10.
Yasuda T, Shimizu J, Miyagawa T, Tsutsumi Y, Iwatsubo T, Tsuji S
Intern Med
. 2024 Mar;
63(19):2679-2682.
PMID: 38432969
A 77-year-old female with a subacute progression of ataxia and serum anti-Yo antibodies was suspected to have paraneoplastic cerebellar degeneration (PCD). An examination of an underlying cancer showed no abnormality...